House Dust Mite Allergy

House Dust Mite Allergy is the indication for 6 drugs in DrugBank. It is covered by 9 curated, structured indications.

Also known as: House dust allergy · Dermatophagoides Farinae Allergy · Allergy to House Dust Mite · Allergy to Dermatophagoides Pteronyssinus · Allergic Rhinitis Due to House Dust Mite
Classified under: Immune System Diseases
Infections
Otorhinolaryngologic Diseases
Respiratory Tract Diseases
Indicated drugs: Cetirizine
Chlorpheniramine
Dermatophagoides farinae
Dermatophagoides pteronyssinus
Fluticasone propionate
Guaifenesin

Resolves to

Vocabularies

MeSHM000752167SNOMED CT195819005MedDRA10020419UMLSC0339807

What you can answer from here — as of October 23, 2026

6Indicated drugsWith each drug's targets and mechanism

Listed above

9Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

44Clinical trialsPhase, status and sponsor resolved per trial

2Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for House Dust Mite Allergy share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.